Viewing the global health system as a complex adaptive system - implications for research and practice.

complex adaptive system; global health system; health system

Journal

F1000Research
ISSN: 2046-1402
Titre abrégé: F1000Res
Pays: England
ID NLM: 101594320

Informations de publication

Date de publication:
2022
Historique:
accepted: 22 09 2022
medline: 22 8 2023
pubmed: 21 8 2023
entrez: 21 8 2023
Statut: epublish

Résumé

The global health system (GHS) is ill-equipped to deal with the increasing number of transnational challenges. The GHS needs reform to enhance global resilience to future risks to health. In this article we argue that the starting point for any reform must be conceptualizing and studying the GHS as a complex adaptive system (CAS) with a large and escalating number of interconnected global health actors that learn and adapt their behaviours in response to each other and changes in their environment. The GHS can be viewed as a multi-scalar, nested health system comprising all national health systems together with the global health architecture, in which behaviours are influenced by cross-scale interactions. However, current methods cannot adequately capture the dynamism or complexity of the GHS or quantify the effects of challenges or potential reform options. We provide an overview of a selection of systems thinking and complexity science methods available to researchers and highlight the numerous policy insights their application could yield.   We also discuss the challenges for researchers of applying these methods and for policy makers of digesting and acting upon them. We encourage application of a CAS approach to GHS research and policy making to help bolster resilience to future risks that transcend national boundaries and system scales.

Identifiants

pubmed: 37600221
doi: 10.12688/f1000research.126201.1
pmc: PMC10432894
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1147

Subventions

Organisme : Medical Research Council
ID : MR/R013454/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 215654/Z/19/Z
Pays : United Kingdom

Informations de copyright

Copyright: © 2022 Borghi J et al.

Déclaration de conflit d'intérêts

No competing interests were disclosed.

Références

J Migr Health. 2022 Mar 19;5:100093
pubmed: 35373166
Health Policy Plan. 2017 Dec 1;32(10):1417-1426
pubmed: 29029075
Stud Health Technol Inform. 2021 Nov 18;287:165-166
pubmed: 34795104
Expert Rev Vaccines. 2022 Jan;21(1):25-36
pubmed: 34758678
BMC Health Serv Res. 2019 Nov 19;19(1):845
pubmed: 31739783
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
J Eval Clin Pract. 2020 Jun;26(3):1030-1033
pubmed: 31922325
EClinicalMedicine. 2022 Jan 27;44:101269
pubmed: 35146401
Glob Soc Policy. 2015 Dec;15(3):212-228
pubmed: 26635495
Health Informatics J. 2009 Jun;15(2):95-107
pubmed: 19474223
J Am Med Inform Assoc. 2018 Feb 1;25(2):210-221
pubmed: 29025116
Nature. 2013 May 2;497(7447):51-9
pubmed: 23636396
Global Health. 2020 Jul 9;16(1):60
pubmed: 32646471
Am J Public Health. 2020 Nov;110(11):1615-1619
pubmed: 33026872
N Engl J Med. 2013 Mar 7;368(10):936-42
pubmed: 23465103
PLoS Med. 2010 May 04;7(5):e1000247
pubmed: 20454566
Health Care Manag Sci. 2016 Mar;19(1):89-101
pubmed: 24715674
Int J Health Policy Manag. 2022 Dec 6;11(11):2769-2772
pubmed: 34124870
Glob Public Health. 2011;6(6):593-605
pubmed: 20432102
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33033054
Adm Policy Ment Health. 2016 Nov;43(6):834-849
pubmed: 27480546
Proc Natl Acad Sci U S A. 2002 May 14;99 Suppl 3:7280-7
pubmed: 12011407
BMC Public Health. 2016 Jun 08;16:487
pubmed: 27277001
Global Health. 2018 Apr 17;14(1):38
pubmed: 29665828
Soc Sci Med. 2021 Sep;285:114277
pubmed: 34343830
Health Res Policy Syst. 2016 May 04;14(1):35
pubmed: 27146327
Health Policy Plan. 2020 Feb 1;35(1):26-35
pubmed: 31625558
Nat Biotechnol. 2021 May;39(5):546-548
pubmed: 33981074
Front Public Health. 2021 Apr 29;9:566499
pubmed: 33996704
Glob Public Health. 2021 Oct 22;:1-17
pubmed: 34686103
Lancet. 2021 Mar 13;397(10278):1023-1034
pubmed: 33587887
Glob Policy. 2022 May;13(2):193-207
pubmed: 35601655
Lancet. 2020 May 9;395(10235):1469-1471
pubmed: 32386579
Sci Rep. 2013 Sep 26;3:2759
pubmed: 24067913
BMC Health Serv Res. 2016 Nov 15;16(Suppl 7):639
pubmed: 28185595
BMJ. 2021 Dec 2;375:n2991
pubmed: 34857541
J Health Polit Policy Law. 2021 Feb 1;46(1):93-116
pubmed: 33085962
Soc Sci Med. 2021 Mar;272:113697
pubmed: 33508655
Int J Qual Health Care. 2021 Mar 5;33(1):
pubmed: 32592480
Confl Health. 2016 Nov 2;10:25
pubmed: 27822297

Auteurs

Josephine Borghi (J)

Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, WC1H 9SH, UK.

Sharif Ismail (S)

Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, WC1H 9SH, UK.

James Hollway (J)

Graduate Institute of International and Development Studies, Geneva, Switzerland.

Rakhyun E Kim (RE)

Copernicus Institute of Sustainable Development, Utrecht University, Utrecht, The Netherlands.

Joachim Sturmberg (J)

School of Medicine and Public Health, University of Newcastle, Callaghan, Australia.

Garrett Brown (G)

School of Politics and International Studies, University of Leeds, Leeds, UK.

Reinhard Mechler (R)

International Institute for Applied Systems Analysis, Laxenberg, Austria.

Heinrich Volmink (H)

Division of Health Systems and Public Health, Stellenbosch University, Stellenbosch, South Africa.

Neil Spicer (N)

Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, WC1H 9SH, UK.

Zaid Chalabi (Z)

Institute for Environmental Design and Engineering, University College London., London, UK.

Rachel Cassidy (R)

Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, WC1H 9SH, UK.

Jeff Johnson (J)

Faculty of Science, Technology, Engineering & Mathematics, The Open University, Milton Keynes, UK.

Anna Foss (A)

Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, WC1H 9SH, UK.

Augustina Koduah (A)

Department of Pharmacy Practice and Clinical Pharmacy, University of Ghana, Accra, Ghana.

Christa Searle (C)

Edinburgh Business School, Heriot Watt University, Edinburgh, UK.

Nadejda Komendantova (N)

International Institute for Applied Systems Analysis, Laxenberg, Austria.

Agnes Semwanga (A)

Health Informatics Research Group, Makerere University, Kampala, Uganda.

Suerie Moon (S)

Graduate Institute of International and Development Studies, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH